no statement of use filed
on 15 Feb 2021
Last Applicant/ Owned by
301 Penobscot Drive
Redwood City
CA
94063
Serial Number
88639660 filed on 02th Oct 2019
Registration Number
N/A
Filing Basis
1. intent to use
2. intent to use current
Disclaimer
NO DATA
Diagnostic kits comprised of medical diagnostic reagents and diagnostic assays for testing tissue samples and bodily fluids for use in cancer detection, analysis and prognosis; medical reagents; medical diagnostic reagents; kits for medical diagnostic purposes consisting primarily of enzymes for medical purposes, and also including nucleic acids, buffers, reagents and assays for use in disease tesRead More
Assays for testing tissue samples and bodily fluids for scientific research in the field of cancer detection, analysis and prognosis; diagnostic assays for testing tissue samples and bodily fluids for scientific research in the field of cancer detection, analysis and prognosis; clinical diagnostic reagents; reagents for scientific or medical research use, namely, reagents for use in preparation of RNA samples; kits consisting primarily of enzymes for scientific and research purposes, and also including nucleic acids, buffers, reagents and assays for use in disease testing; diagnostic kits comprised primarily of diagnostic reagents for clinical or medical laboratory use and diagnostic assays for testing tissue samples and bodily fluids for clinical or medical laboratory use in cancer detection, analysis and prognosis; diagnostic kits comprised primarily of enzymes for scientific and research purposes, and also including nucleic acids, buffers, reagents and assays for use in disease testing; clinical diagnostic reagents
Diagnostic kits comprised of medical diagnostic reagents and diagnostic assays for testing tissue samples and bodily fluids for use in cancer detection, analysis and prognosis; medical reagents; medical diagnostic reagents; kits for medical diagnostic purposes consisting primarily of enzymes for medical purposes, and also including nucleic acids, buffers, reagents and assays for use in disease testing and classification; diagnostic kits consisting primarily of enzymes for medical purposes, and also including nucleic acids, buffers, reagents and assays for use in disease testing and classification; medical diagnostic assays for testing of bodily fluids and tissue samples for use in disease detection and testing for medical and prognostic purposes; medical diagnostic reagents and assays for testing bodily fluids and tissue samples for use in disease testing and classification; enzyme preparations for medical purposes; biological preparations for the detection, diagnosis and monitoring of cancer for medical purposes; preparations for detecting genetic predispositions for medical purposes; biological preparations for use in the diagnosis, analysis and prognosis of cancer for medical purposes; diagnostic agents, preparations and substances for medical purposes
Providing laboratory research services in the field of gene expression, namely, cancer biology; Providing medical testing services and information in the field of cancer research and disease classification
Medical testing for diagnostic and prognostic purposes in the field of cancer and disease classification; providing medical information to medical professionals in the form of reports in the field of cancer and disease classification
No 88639660
No Service Mark
No
No
No
No
No
No
No
No
No
| Status Date | Action Taken |
|---|---|
| 16th Feb 2021 | ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED |
| 15th Feb 2021 | ABANDONMENT - NO USE STATEMENT FILED |
| 14th Jul 2020 | NOA E-MAILED - SOU REQUIRED FROM APPLICANT |
| 19th Jun 2020 | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED |
| 19th Jun 2020 | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED |
| 19th Jun 2020 | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED |
| 19th Jun 2020 | TEAS CHANGE OF CORRESPONDENCE RECEIVED |
| 19th Jun 2020 | TEAS CHANGE OF OWNER ADDRESS RECEIVED |
| 19th May 2020 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| 19th May 2020 | PUBLISHED FOR OPPOSITION |
